The Serum Institute of India, the world’s largest vaccine manufacturer, is expecting to launch another COVID-19 vaccine called Covovax by June, the company’s CEO Adar Poonawalla said on Saturday. The…
SII
-
-
Free Fire has a wide variety of in-game cosmetic items like costumes, emotes and . Most of these items can be obtained using diamonds, one of the currencies in the…
- News
SII fire accident or sabotage to be known after probe, says Maharashtra CM Uddhav Thackeray – India News , Firstpost
Five men died in the fire that bre out in a five-storeyed under-construction building in the SII’s Manjari premises in Pune on Thursday File image of Uddhav Thackeray. @OfficeofUT Pune:…
- News
Coronavirus LIVE Updates: Pune Police Crime Branch to Probe SII Fire That Killed 5; Vaccine Recipients to Share ‘1st-hand Experience’ with Modi
It is learnt that two million doses each will be sent as commercial supplies to Brazil and Morocco, while a consignment of 1.5 million doses of Covishield will be ivered…
- News
Fire at Serum Institute of India LIVE Updates: ‘Anguished to learn of loss of lives’, Union minister Harsh Vardhan condoles five killed in SII blaze – India News , Firstpost
Fire at Serum Institute of India LIVE Updates: Five persons were killed in a blaze that bre out today afternoon at SII plant in Pune’s Manjari area. Maharshtra chief minister…
-
The Union Health Ministry announced Tuesday all vaccine doses, 1.10 crore from Serum Insititute of India and 55 lakh from Bharat Biotech, will be given to all states and Union…
- News
Centre orders 11 mn doses of Oxford-AstraZeneca vaccine from SII at Rs 210 each – India News , Firstpost
Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India Representational image. PTI New hi: The…
- News
Preps in Full Swing for Vaccine Roll-out, CMs to Interact with Modi; SII May Begin Transporting Virus Jabs Today
A day before chief ministers’ interaction with Prime Minister Narendra Modi, several states on Sunday said they have made all necessary preparations for the first phase of nationwide roll-out of…
- News
SII, Bharat Biotech engage in war of words: A look at controversies surrounding vaccines cleared by DCGI – Health News , Firstpost
The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India to place after the DCGI announced the approval of the Covaxin and Covishield vaccines Representational image.…
-
The Serum Institute of India (SII) clarified on Monday that the company is yet to receive the permission from the authority here to export its Covid-19 vaccine to other nations,…
-
Mumbai: The vaccination drive for the recently approved coronavirus vaccine can start in the country from this month. On Sunday, Drug Controller General of India (DCGI) VG Somani approved Serum…
-
India’s drugs regulator has given final emergency-use approval for two coronavirus vaccines — Serum Institute of India’s Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech’s Covaxin.…
- News
Pfizer-BioNTech requests more time, India’s SEC to meet on January 1 to authorise SII, Bharat Biotech vaccines
India’s Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) met on Wednesday to consider coronavirus vaccines for emergency use authorisation (EUA) requested by Pfizer-BioNTech, Bharat Biotech and…
- News
Govt needs to protect vaccine manufacturers against all lawsuits, says SII CEO Adar Poonawalla – India News , Firstpost
Last month, SII had rejected allegations of serious side-effects made by a participant in the Covishield vaccine trial in Chennai. The man had also sought Rs 5 crore compensation Adar…
- News
India may commence COVID-19 vaccination drive by Jan, normal life will resume by Oct: SII CEO Adar Poonawalla
The Serum Institute of India (SII) CEO Adar Poonawalla informed that the COVID-19 vaccination in India is likely to start by January 2021. He further said that his company is…
- News
DCGI expert panel asks SII, BHARAT Biotech to provide more safety, efficacy data for Covid-19 vaccines
In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for safety and efficacy data from Serum Institute…
- News
Bharat Biotech seeks emergency use authorisation for Covaxin days after Pfizer and SII – India News , Firstpost
Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine ‘may be ready in a few weeks’ at an all-party meeting COVAXIN vaccine by Bharath Biotech. New hi: After…
-
Stressing that the Covishield vaccine is “safe and immunogenic”, the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by…
- News
SII rejects Covishield volunteer’s allegations; PM to interact with 3 teams making COVID vaccine tomorrow – Health News , Firstpost
A 40-year-old man who to part in the ‘Covishield’ vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has…
- News
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla
The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday…